CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-16 | BARRIS PETER J 10% owner | Option exercise · Warrant to Purchase Common Stock (right to buy) | −9,445 | $0.33 | $3K | 0 |
| 2015-11-16 | BARRETT M JAMES Director | Option exercise | +9,445 | $0.33 | $3K | 4,491,203 |
| 2015-11-16 | BARRETT M JAMES Director | Sale | −452 | $6.91 | $3K | 4,490,751 |
| 2015-11-16 | BARRETT M JAMES Director | Option exercise · Warrant to Purchase Common Stock (right to buy) | −9,445 | $0.33 | $3K | 0 |
| 2015-11-16 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise | +9,445 | $0.33 | $3K | 4,491,203 |
| 2015-11-16 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Sale | −452 | $6.91 | $3K | 4,490,751 |
| 2015-11-16 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise · Warrant to Purchase Common Stock (right to buy) | −9,445 | $0.33 | $3K | 0 |
| 2015-07-15 | BARRETT M JAMES Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-07-15 | PEARSON TIMOTHY R Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-07-15 | Baldwin John J. Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-07-15 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-07-15 | TOP FRANKLIN H JR Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-07-15 | HENOS MICHAEL A Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2015-02-27 | Hahn Brian M. CFO | Option exercise | +5,000 | $1.12 | $6K | 14,085 |
| 2015-02-27 | Hahn Brian M. CFO | Option exercise · Employee Stock Option (right to buy) | −5,000 | 10,520 | ||
| 2015-02-24 | King Rachel K. President, CEO | Option exercise | +50,000 | $1.12 | $56K | 167,206 |
| 2015-02-24 | King Rachel K. President, CEO | Option exercise · Employee Stock Option (right to buy) | −50,000 | 297,580 | ||
| 2015-01-08 | Magnani John L. VP of Research, CSO | Grant or award · Employee Stock Option (right to buy) | +71,000 | 71,000 | ||
| 2015-01-08 | Thackray Helen M. VP Clinical Development, CMO | Grant or award · Employee Stock Option (right to buy) | +71,000 | 71,000 | ||
| 2015-01-08 | King Rachel K. President, CEO | Grant or award · Employee Stock Option (right to buy) | +141,000 | 141,000 |
Page 17 of 20 · 397 trades